NOV 24, 2019 11:38 PM PST

The unlikely pain killer

WRITTEN BY: Nouran Amin

Pain can be anything a sunburn, a toothache, or a leg injury to name a few. The relievers that target our pain come in many colors—one being morphine, a widely used opioid.

Learn more about the biology of pain:

Now, a graduate student at West Virginia University, Shane Kaski, is studying how an anti-itch medication can be effective at relieving pain. Specifically, Kaski is examining how the drug ‘nalfurafine’ targets a certain region of our nerve cells that can make morphine more effective. The research could potentially fight against opioid addiction by making patients less reliant on morphine. Essentially, nalfurafine could serve as a ‘supplement’.

"Right now there's a lot of work looking for replacements for opioids, for obvious reasons," said Kaski, a graduate student in the School of Medicine's M.D./Ph.D. program. "Maybe nalfurafine is not so great as a replacement on its own, but maybe it does enough that we could put it together with other opioids and get this dose-sparing effect."

Using a supplemental dose of nalfurafine along with a decreased dose of morphine was found to reduce as much pain as a large dose of morphine alone. The findings of the study were published in the Journal of Pharmacology and Experimental Therapeutics.

"It's possible that you just need a tiny smidgen of nalfurafine with a smidgen of this other addictive drug to get the equivalent pain relief from a larger dose of your addictive drug," he said. "That's what we're seeing in our early work. That's the promise that we saw."

However, there is a paradox—because to fight the opioid addiction, we use another opioid. Nalfurafine, like morphine, is an opioid. But, how exactly is that supposed to work? The answer to that is through pain receptors.

“Why are you going to use another opioid on top of morphine? It comes down to the specifics of the biology of opioid receptors,” says Kaski. "The biggest three opioid receptors you'll hear about are mu, kappa and delta.”

“Nalfurafine is unusual. Even though it's an opioid, it doesn't have a permit to park in mu. Instead it parks in the kappa receptor. Once it does, it alleviates pain while also "putting the brakes on" the reward circuit that can lead to addiction,” Kaski adds.

Source: West Virginia University

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 10, 2020
Drug Discovery & Development
A Highly Targeted Cancer Therapeutic
JUN 10, 2020
A Highly Targeted Cancer Therapeutic
A study led by researchers at USC School of Pharmacy discusses a way to engineer drugs that highly target malignant tiss ...
JUN 19, 2020
Drug Discovery & Development
First Treatment To Prevent Anaphylaxis
JUN 19, 2020
First Treatment To Prevent Anaphylaxis
People living with food or drug allergies are always faced with potential life-threatening anaphylactic shock. Currently ...
JUL 16, 2020
Cardiology
A New Drug Candidate to Combat Cardiac Fibrosis
JUL 16, 2020
A New Drug Candidate to Combat Cardiac Fibrosis
Medicine is undoubtedly reaching a golden age, as researchers expand diagnostic and therapeutic tools like never before. ...
JUL 19, 2020
Drug Discovery & Development
Study Finds Turmeric has Antiviral Effects
JUL 19, 2020
Study Finds Turmeric has Antiviral Effects
Researchers from the Wuhan University of Engineering in China have found that curcumin, a natural compound found in turm ...
JUL 24, 2020
Cancer
A New Biomarker Candidate for Cancer Diagnostics
JUL 24, 2020
A New Biomarker Candidate for Cancer Diagnostics
One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal ...
JUL 14, 2020
Drug Discovery & Development
Antiplatelet Drug Shows Promise for Heart Attack Treatment
JUL 14, 2020
Antiplatelet Drug Shows Promise for Heart Attack Treatment
A common and often dangerous side-effect of antiplatelet medications is an increase in bleeding. As such, researchers at ...
Loading Comments...